Transplanting Lungs From Uncontrolled Donation After Circulatory Death

Launched by NYU LANGONE HEALTH · Mar 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new method for using lungs from donors who have passed away due to a lack of blood flow, known as uncontrolled donation after circulatory death (uDCD). The research team has developed a way to keep these lungs healthy for just over three hours after death using a special technique that helps maintain pressure and oxygen levels in the lungs. By closely monitoring the entire process, the study aims to determine how safe and effective this method is for lung transplantation. They will track various outcomes, including how many lungs are successfully preserved, how well they perform during testing, and the health of patients after receiving a transplant.

To participate in this trial, you must be a patient currently waiting for a lung transplant and willing to be part of the research. Unfortunately, if you cannot be followed for one year after the transplant or cannot give your consent, you would not be eligible. If you join the study, you can expect a thorough evaluation of your health and the health of the lungs before transplantation, as well as ongoing monitoring after the procedure to ensure your safety and well-being. This trial is crucial as it could help improve the availability of donor lungs and support more patients in need of transplants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients waiting for lung transplants
• • Willing to participate in the research study
• Exclusion Criteria:
• • Unable to be followed for 1 year after transplantation
• • Unable to provide written informed consent to participate in the research (or designate a surrogate)